本页面由Tiger Trade Technology Pte. Ltd.提供服务

Ventyx Biosciences, Inc.

14.00
0.0000
成交量:- -
成交额:7,625.72万
市值:10.05亿
市盈率:-9.34
高:14.00
开:14.00
低:14.00
收:14.00
52周最高:25.00
52周最低:0.7830
股本:7,175.01万
流通股本:5,355.59万
量比:- -
换手率:- -
股息:- -
股息率:- -
每股收益(TTM):-1.4991
每股收益(LYR):-1.9732
净资产收益率:-45.35%
总资产收益率:-28.47%
市净率:5.25
市盈率(LYR):-7.10

数据加载中...

2024/05/16

重要事件披露

Form 8-K - Current report
2024/05/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/09

重要事件披露

Form 8-K - Current report
2024/04/26

SEC问询函

Form CORRESP - Correspondence
2024/04/05

重要事件披露

Form 8-K - Current report
2024/04/04

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/04/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/21

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/03/13

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/03/11

重要事件披露

Form 8-K - Current report
2024/03/08

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/03/07

重要事件披露

Form 8-K - Current report
2024/02/28

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/28

重要事件披露

Form 8-K - Current report
2024/02/23

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/15

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals